Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.
Read Full NewsPaul Melmeyer, MPP, executive vice president, public policy and advocacy, Muscular Dystrophy Association, explains how adding Duchenne muscular dystrophy to the Recommended Unified Screening Panel reshapes early diagnosis, treatment timing, and family counseling.
The HCPFive: Top News for Healthcare Providers from the Week of 01/11
1.
Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.
2.
Young adults who are obese are at risk for 17 different types of cancer in the future.
3.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
4.
For patients with prostate cancer, long-term follow-up helps identify treatment side effects.
5.
Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.
1.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
2.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
3.
How Cancer Cells Evade Immune Destruction and the Fight Back
4.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
5.
Understanding the Importance of Knowing Your MCV Normal Range
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge